116 filings
8-K
CARA
Cara Therapeutics Inc
13 May 24
Cara Therapeutics Reports First Quarter 2024 Financial Results
4:10pm
8-K
CARA
Cara Therapeutics Inc
22 Mar 24
Departure of Directors or Certain Officers
4:05pm
8-K
CARA
Cara Therapeutics Inc
4 Mar 24
Cara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results
4:10pm
8-K
CARA
Cara Therapeutics Inc
2 Feb 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:59pm
8-K
CARA
Cara Therapeutics Inc
22 Jan 24
Cost Associated with Exit or Disposal Activities
4:19pm
8-K
i08sd
18 Dec 23
Regulation FD Disclosure
7:10am
8-K
2hkaw5l
13 Nov 23
Corporate Presentation November 2023
4:28pm
8-K
f040ktrxmacz jj
13 Nov 23
Cara Therapeutics Reports Third Quarter 2023 Financial Results
4:11pm
8-K
n8k9xdgd920whtgpguz
2 Nov 23
Cara Therapeutics Announces up to $40.0 Million Non-Dilutive Financing Agreement with HealthCare Royalty
7:10am
8-K
plbq0cxq
7 Aug 23
Corporate Presentation August 2023
4:24pm
8-K
hwputdtel 4ck
7 Aug 23
Cara Therapeutics Reports Second Quarter 2023 Financial Results
4:10pm
8-K
rdwc417lljmrp
3 Aug 23
Cara Therapeutics Appoints Helen M. Boudreau to
7:06am
8-K
03mvnvbm2li9tgn6ox
2 Jun 23
Submission of Matters to a Vote of Security Holders
4:06pm
8-K
f39c sr0pmiuf
15 May 23
Corporate Presentation May 2023
4:21pm
8-K
50u58cjhsargq51 z1
15 May 23
Cara Therapeutics Reports First Quarter 2023 Financial Results
4:10pm
8-K
e7quax vjlba2msv
23 Mar 23
Corporate Presentation March 2023
5:04pm
8-K
x42bscvk3n3uyt dr
10 Mar 23
Regulation FD Disclosure
5:03pm
8-K
y3gnwxvsv jep
6 Mar 23
Cara Therapeutics Announces Fourth Quarter and Full Year 2022 Financial Results
4:10pm
8-K
s282q0 kz531yxisg
9 Jan 23
Regulation FD Disclosure
7:00am
8-K
i7av03 qz2njnmy8
7 Nov 22
Regulation FD Disclosure
4:47pm